CardioGenics Holdings Inc
CardioGenics Holdings Inc
- Market cap
- $12.00K
Your view on CGNH
Overview
What the company does, where it operates, and who runs it.
About CardioGenics Holdings Inc
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Yahia Abdul Gawad
- Headquarters
- 6295 Northam Drive, Mississauga, ON, CA
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Yahia Abdul Gawad
- Headquarters
- 6295 Northam Drive, Mississauga, ON, CA
CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally.
Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.
The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for CardioGenics Holdings Inc. Starting points for CardioGenics Holdings Inc: EPS -$0.02, beta 20.77 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for CardioGenics Holdings Inc. CardioGenics Holdings Inc does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for CardioGenics Holdings Inc. Trailing twelve-month EPS for CardioGenics Holdings Inc stands at -$0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for CardioGenics Holdings Inc. CardioGenics Holdings Inc has reported as a listed company since 2004. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| WGSGeneDx Holdings Corp. | Healthcare | NASDAQ | $1.4B | ||
| WUXAYWuXi AppTec Co., Ltd. | Healthcare | OTC | $45.6B | ||
| WUXIFWuXi AppTec Co., Ltd. | Healthcare | OTC | $39.8B | ||
| XGNExagen Inc. | Healthcare | NASDAQ | $92.1M | ||
| SKHHYSonic Healthcare Limited | Healthcare | OTC | $8.2B | ||
| SLDXStella Diagnostics Inc. | Healthcare | OTC | $1.4M | ||
| SPDESpeedus Corp. | Healthcare | OTC | $416 | ||
| SZLSFStageZero Life Sciences Ltd. | Healthcare | OTC | $61,766 | ||
| TDSGFTelo Genomics Corp. | Healthcare | OTC | $3.8M | ||
| TELO.VTelo Genomics Corp. | Healthcare | TSXV | $4.0M | ||
| THOXFBioPorto A/S | Healthcare | OTC | $73.8M | ||
| TMOThermo Fisher Scientific Inc. | Healthcare | NYSE | $248.1B | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for CardioGenics Holdings Inc. Coverage tracks CardioGenics Holdings Inc within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of CardioGenics Holdings Inc.